{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:03:41Z","timestamp":1792458221577,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21MH113871"],"award-info":[{"award-number":["R21MH113871"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS102225"],"award-info":[{"award-number":["R01NS102225"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopsych.2021.05.021","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T01:55:35Z","timestamp":1622426135000},"page":"449-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4495-2754","authenticated-orcid":false,"given":"Timothy B.","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-182X","authenticated-orcid":false,"given":"Jonathan","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2021.05.021_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2019.07.039","article-title":"A\u00a0review of the molecular mechanisms of traumatic brain injury","volume":"131","author":"Ladak","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.biopsych.2021.05.021_bib3","first-page":"1307","article-title":"The pathophysiology of traumatic brain injury at a glance","volume":"6","author":"Prins","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.biopsych.2021.05.021_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pmr.2016.01.003","article-title":"The molecular pathophysiology of concussive brain injury\u2014An update","volume":"27","author":"Barkhoudarian","year":"2016","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.biopsych.2021.05.021_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nec.2016.06.002","article-title":"Pathophysiology of traumatic brain injury","volume":"27","author":"McGinn","year":"2016","journal-title":"Neurosurg Clin N Am"},{"issue":"suppl 4","key":"10.1016\/j.biopsych.2021.05.021_bib6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1227\/NEU.0000000000000505","article-title":"The new neurometabolic cascade of concussion","volume":"75","author":"Giza","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biopsych.2021.05.021_bib7","first-page":"511","article-title":"Association of traumatic brain injury with subsequent neurological and psychiatric disease: A meta-analysis","volume":"124","author":"Perry","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.biopsych.2021.05.021_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.07.007","article-title":"Depression following adult, non-penetrating traumatic brain injury: A meta-analysis examining methodological variables and sample characteristics","volume":"47","author":"Osborn","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2021.05.021_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bjsports-2017-097791","article-title":"A\u00a0systematic review of potential long-term effects of sport-related concussion","volume":"51","author":"Manley","year":"2017","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.biopsych.2021.05.021_bib10","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1097\/HTR.0000000000000514","article-title":"A\u00a0systematic review and meta-analysis on PTSD following TBI among military\/veteran and civilian populations","volume":"35","author":"Loignon","year":"2020","journal-title":"J\u00a0Head Trauma Rehabil"},{"key":"10.1016\/j.biopsych.2021.05.021_bib11","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1089\/neu.2018.5759","article-title":"Post-traumatic stress disorder after civilian traumatic brain injury: A\u00a0systematic review and meta-analysis of prevalence rates","volume":"36","author":"Van Praag","year":"2019","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s10072-020-04458-7","article-title":"Post-traumatic stress disorder after traumatic brain injury-A systematic review and meta-analysis","volume":"41","author":"Iljazi","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: Time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2021.05.021_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00401-018-1944-6","article-title":"The complexity of neuroinflammation consequent to traumatic brain injury: From research evidence to potential treatments","volume":"137","author":"Morganti-Kossmann","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: From evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nri3042","article-title":"Reciprocal regulation of the neural and innate immune systems","volume":"11","author":"Irwin","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: Double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2021.05.021_bib21","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1172\/JCI61884","article-title":"Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression","volume":"122","author":"Kim","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2021.05.021_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1742-2094-10-87","article-title":"Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors","volume":"10","author":"Lawson","year":"2013","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.biopsych.2021.05.021_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: A finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib25","article-title":"The kynurenine pathway in bipolar disorder: A meta-analysis on the peripheral blood levels of tryptophan and related metabolites","author":"Bartoli","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.biopsych.2021.05.021_bib27","article-title":"Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid","volume":"1\u201310","author":"Savitz","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2021.05.021_bib28","doi-asserted-by":"crossref","first-page":"102559","DOI":"10.1016\/j.nicl.2021.102559","article-title":"Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder","volume":"29","author":"Tsuchiyagaito","year":"2021","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.biopsych.2021.05.021_bib29","doi-asserted-by":"crossref","first-page":"C836","DOI":"10.1152\/ajpcell.00053.2016","article-title":"Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans","volume":"310","author":"Schlittler","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbi.2021.04.020","article-title":"Toward a neuroprotective shift: Eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive humans\u2014A randomized controlled trial","volume":"96","author":"Javelle","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66\u201367","author":"Halaris","year":"2015","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","article-title":"Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression","volume":"74","author":"Zhou","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbi.2019.06.033","article-title":"Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine","volume":"81","author":"Verdonk","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib34","article-title":"The kynurenine pathway and bipolar disorder: Intersection of the monoaminergic and glutamatergic systems and immune response","author":"Kadriu","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrrheum.2017.172","article-title":"The brain and immune system prompt energy shortage in chronic inflammation and ageing","volume":"13","author":"Straub","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1\u03b2: A new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"Fujigaki","year":"2006","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib38","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Gu\u00e9rin","volume":"29","author":"O\u2019Connor","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","article-title":"The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen","volume":"16","author":"Lestage","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib40","first-page":"e69","article-title":"The relationship between saliva cortisol measures, symptom burden, length of recovery and concussion history following pediatric sport-related concussion","volume":"29","author":"La","year":"2019","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.biopsych.2021.05.021_bib41","doi-asserted-by":"crossref","first-page":"32987","DOI":"10.1038\/srep32987","article-title":"Endocrine dysfunction following traumatic brain injury: A 5-year follow-up nationwide-based study","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2021.05.021_bib42","first-page":"2752","article-title":"Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury","volume":"86","author":"Lieberman","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2021.05.021_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","article-title":"Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A systematic review","volume":"298","author":"Schneider","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2021.05.021_bib44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A\u00a0glycine site associated with N-methyl-d-aspartic acid receptors: Characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2021.05.021_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0701834","article-title":"Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid","volume":"124","author":"Harris","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib47","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: Physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib48","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2021.05.021_bib50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0014-4886(84)90239-5","article-title":"Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat","volume":"84","author":"Foster","year":"1984","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib51","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS Journal"},{"key":"10.1016\/j.biopsych.2021.05.021_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4522(92)90467-G","article-title":"Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse","volume":"51","author":"Saito","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2021.05.021_bib53","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib55","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: Implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(94)91601-2","article-title":"Kynurenate is neuroprotective following experimental brain injury in the rat","volume":"655","author":"Hicks","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(95)00179-T","article-title":"Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats","volume":"678","author":"Hicks","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib58","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.13-12-05383.1993","article-title":"Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury","volume":"13","author":"Smith","year":"1993","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1471-4159.1997.68010280.x","article-title":"Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues","volume":"68","author":"Heyes","year":"1997","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2021.05.021_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and \u03b22-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2021.05.021_bib64","first-page":"1147","article-title":"Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans","volume":"74","author":"Hay","year":"2015","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00401-018-1824-0","article-title":"Mechanical disruption of the blood\u2013brain barrier following experimental concussion","volume":"135","author":"Johnson","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093344","article-title":"Mechanisms of blood\u2013brain barrier dysfunction in traumatic brain injury","volume":"21","author":"Cash","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib67","first-page":"889","article-title":"Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury","volume":"73","author":"Katayama","year":"1990","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.biopsych.2021.05.021_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jcbfm.1992.3","article-title":"Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury","volume":"12","author":"Kawamata","year":"1992","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2021.05.021_bib69","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0006-8993(94)01444-M","article-title":"Lactate accumulation following concussive brain injury: The role of ionic fluxes induced by excitatory amino acids","volume":"674","author":"Kawamata","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1179\/016164107X251745","article-title":"Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury","volume":"30","author":"Suma","year":"2008","journal-title":"Neurol Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/neu.2017.5450","article-title":"Traumatic injury leads to inflammation and altered tryptophan metabolism in the juvenile rabbit brain","volume":"36","author":"Zhang","year":"2018","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12640-009-9044-y","article-title":"Metallothionein treatment attenuates microglial activation and expression of neurotoxic quinolinic acid following traumatic brain injury","volume":"15","author":"Chung","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jnr.24489","article-title":"Modification of kynurenine pathway via inhibition of kynurenine hydroxylase attenuates surgical brain injury complications in a male rat model","volume":"98","author":"Zakhary","year":"2020","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib74","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1167\/iovs.19-27565","article-title":"Blast preconditioning protects retinal ganglion cells and reveals targets for prevention of neurodegeneration following blast-mediated traumatic Brian injury","volume":"60","author":"Harper","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","article-title":"Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans","volume":"18","author":"Sinz","year":"1998","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2021.05.021_bib76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00003246-199903000-00023","article-title":"Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury","volume":"27","author":"Bell","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.biopsych.2021.05.021_bib77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12974-015-0328-2","article-title":"Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans","volume":"12","author":"Yan","year":"2015","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.biopsych.2021.05.021_bib78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01220.x","article-title":"Tryptophan metabolism and oxidative stress in patients with chronic brain injury","volume":"13","author":"Mackay","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.22455","article-title":"Inflammation after trauma: Microglial activation and traumatic brain injury","volume":"70","author":"Ramlackhansingh","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","article-title":"Inflammation and white matter degeneration persist for years after a single traumatic brain injury","volume":"136","author":"Johnson","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2021.05.021_bib81","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2967\/jnumed.110.084061","article-title":"Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury","volume":"52","author":"Folkersma","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2021.05.021_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaneurol.2016.3764","article-title":"Imaging of glial cell activation and white matter integrity in brains of active and recently retired national football league players","volume":"74","author":"Coughlin","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2014.10.019","article-title":"Neuroinflammation and brain atrophy in former NFL players: An in\u00a0vivo multimodal imaging pilot study","volume":"74","author":"Coughlin","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2021.05.021_bib84","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1089\/neu.2018.6055","article-title":"Prevalence of potentially clinically significant magnetic resonance imaging findings in athletes with and without sport-related concussion","volume":"36","author":"Klein","year":"2019","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib85","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jnnp-2015-311369","article-title":"Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion","volume":"87","author":"Singh","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib86","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/neu.2015.4118","article-title":"Smaller dentate gyrus and CA2 and CA3 volumes are associated with kynurenine metabolites in collegiate football athletes","volume":"33","author":"Meier","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib88","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib89","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/neu.2016.4599","article-title":"Abnormalities in functional connectivity in collegiate football athletes with and without a concussion history: Implications and role of neuroactive kynurenine pathway metabolites","volume":"34","author":"Meier","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib90","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbi.2020.03.002","article-title":"Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites","volume":"87","author":"Meier","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib91","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbi.2020.11.011","article-title":"Positive association between serum quinolinic acid and functional connectivity following concussion","volume":"91","author":"Meier","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1037\/neu0000110","article-title":"Hyperconnectivity is a fundamental response to neurological disruption","volume":"29","author":"Hillary","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib93","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hbm.24440","article-title":"Resting-state functional connectivity after concussion is associated with clinical recovery","volume":"40","author":"Kaushal","year":"2019","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2021.05.021_bib94","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1089\/neu.2017.5185","article-title":"The default mode network as a biomarker of persistent complaints after mild traumatic brain injury: A longitudinal functional magnetic resonance imaging study","volume":"34","author":"Van Der Horn","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2021.05.021_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.biopsych.2021.05.021_bib96","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001756-199701200-00011","article-title":"Activated human microglia produce the excitotoxin quinolinic acid","volume":"8","author":"Espey","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.biopsych.2021.05.021_bib97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib98","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2015.08.002","article-title":"Priming the inflammatory pump of the CNS after traumatic brain injury","volume":"38","author":"Witcher","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib99","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1189\/jlb.0208108","article-title":"Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system","volume":"84","author":"Dilger","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-\u03b1-induced depressive symptoms: A shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: Evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2021.05.021_bib102","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.biopsych.2021.05.021_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A\u00a0role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib105","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1038\/tp.2017.88","article-title":"Serum kynurenic acid is reduced in affective psychosis","volume":"7","author":"Wurfel","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2016.04.007","article-title":"Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression","volume":"56","author":"Young","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib107","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/acschemneuro.0c00636","article-title":"Roflumilast, a cAMP-specific Phosphodiesterase-4 inhibitor, reduces oxidative stress and improves synapse functions in human cortical neurons exposed to the excitotoxin quinolinic acid","volume":"11","author":"Bhat","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib108","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-020-09976-x","article-title":"Kynurenic acid protects against reactive glial-associated reductions in the complexity of primary cortical neurons","author":"O\u2019Reilly","year":"2021","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib109","doi-asserted-by":"crossref","first-page":"36489","DOI":"10.1038\/srep36489","article-title":"Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical\u00a0connectivity and hippocampal synaptic plasticity","volume":"6","author":"Latif-Hernandez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2021.05.021_bib110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpsychires.2012.10.020","article-title":"Hippocampal volume and total cell numbers in major depressive disorder","volume":"47","author":"Cobb","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2021.05.021_bib111","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1212\/WNL.58.10.1476","article-title":"Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun study","volume":"58","author":"Gosche","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib112","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1038\/ncomms8582","article-title":"Voxel-based morphometry predicts shifts in dendritic spine density and morphology with auditory fear conditioning","volume":"6","author":"Keifer","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2021.05.021_bib113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuropharm.2011.09.003","article-title":"The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building?","volume":"62","author":"Petrik","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib114","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.08.022","article-title":"Cellular changes in the postmortem hippocampus in major depression","volume":"56","author":"Stockmeier","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biopsych.2017.09.006","article-title":"Smaller hippocampal volume in posttraumatic stress disorder: A multisite ENIGMA-PGC study: Subcortical volumetry results from posttraumatic stress disorder consortia","volume":"83","author":"Logue","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib116","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA Major Depressive Disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib117","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mp.2016.72","article-title":"Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: Evidence from voxel-based meta-analysis","volume":"22","author":"Wise","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib118","doi-asserted-by":"crossref","first-page":"287","DOI":"10.31887\/DCNS.2011.13.2\/tmcallister","article-title":"Neurobiological consequences of traumatic brain injury","volume":"13","author":"McAllister","year":"2011","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib119","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1037\/0894-4105.21.5.515","article-title":"Anterior and middle cranial fossa in traumatic brain injury: Relevant neuroanatomy and neuropathology in the study of neuropsychological outcome","volume":"21","author":"Bigler","year":"2007","journal-title":"Neuropsychology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib120","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1523\/JNEUROSCI.05-11-02909.1985","article-title":"Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain","volume":"5","author":"Monaghan","year":"1985","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib122","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: Cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2021.05.021_bib123","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2021.05.021_bib124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","article-title":"Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder","volume":"82","author":"Stolk","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.biopsych.2021.05.021_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acps.12957","article-title":"New drug candidates for depression\u2014A nationwide population-based study","volume":"139","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2021.05.021_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01020-5","article-title":"Effects of aspirin on the long-term management of depression in older people: A double-blind randomised placebo-controlled trial","author":"Berk","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib127","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ijnp\/pyaa025","article-title":"A\u00a0randomized trial of the N-methyl-d-aspartate receptor glycine site antagonist prodrug 4-Chlorokynurenine in treatment-resistant depression","volume":"23","author":"Park","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib128","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41380-018-0076-7","article-title":"Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice","volume":"24","author":"Walker","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.05.021_bib129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2019.00778","article-title":"Systematic review on the involvement of the kynurenine pathway in stroke: Pre-clinical and Clinical Evidence","volume":"10","author":"Colpo","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2174\/1381612822666151214125950","article-title":"The kynurenine pathway in the acute and chronic phases of cerebral ischemia","volume":"22","author":"Cuartero","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2021.05.021_bib131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/CS20080319","article-title":"Tryptophan degradation in multiple trauma patients: Survivors compared with non-survivors","volume":"116","author":"Ploder","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.biopsych.2021.05.021_bib132","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2021.05.021_bib133","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2021.05.021_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2021.05.021_bib135","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov Disord"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232101338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232101338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:14:39Z","timestamp":1757776479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632232101338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":134,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S000632232101338X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2021.05.021","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2021.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}